Asymmetric hydrogenation, wherein a double bond is reduced using molecular hydrogen, is a popular way to add a stereocenter to a molecule. But asymmetric hydrogenation tends to break oximes’ N–O bonds ...
Janice Chambers is an author of a US patent owned by Mississippi State University on these oxime antidotes, and the oxime platform is licensed by Defender Pharmaceuticals. She has received funding on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results